Lead tetroxide (Pb3O4)

Lead tetroxide (Pb3O4), also known as red lead or minium, is an inorganic compound and a significant environmental toxicant rather than a therapeutic target or receptor (PubChem CID 166851). It is primarily used in industrial applications such as lead-acid batteries, rust-inhibiting primers, and glass manufacturing (Wikipedia, "Lead(II,IV) oxide"). In a biological context, lead tetroxide is highly hazardous; upon ingestion or inhalation, it serves as a source of lead ions that disrupt various physiological processes by mimicking essential cations like calcium and zinc and inhibiting key enzymes such as aminolevulinic acid dehydratase (ALAD) (ATSDR, 2020). This interference leads to lead poisoning, which is characterized by symptoms ranging from anemia and abdominal pain to severe neurological deficits and renal failure (StatPearls, "Lead Toxicity"). While no drugs are designed to activate or inhibit lead tetroxide for therapeutic benefit, pharmacological treatment for exposure involves chelating agents such as Succimer or Edetate calcium disodium, which sequester lead ions to promote their excretion (Mayo Clinic, 2023). Because it is a hazardous chemical substance rather than a biological receptor, it is classified as an incorrect target for drug discovery purposes.

Other names

Red leadMiniumTrilead tetroxideLead(II,IV) oxideC.I. Pigment Red 105

Lead tetroxide is a toxicant; pharmacological intervention involves chelation therapy where drugs bind lead ions to facilitate renal excretion.